ATE192442T1 - Bernsteinsäuremonoamidverbindung, verfahren zur deren herstellung und deren verwendung - Google Patents

Bernsteinsäuremonoamidverbindung, verfahren zur deren herstellung und deren verwendung

Info

Publication number
ATE192442T1
ATE192442T1 AT94921848T AT94921848T ATE192442T1 AT E192442 T1 ATE192442 T1 AT E192442T1 AT 94921848 T AT94921848 T AT 94921848T AT 94921848 T AT94921848 T AT 94921848T AT E192442 T1 ATE192442 T1 AT E192442T1
Authority
AT
Austria
Prior art keywords
pharmaceutically acceptable
succinamic acid
acceptable salt
acid compound
present
Prior art date
Application number
AT94921848T
Other languages
English (en)
Inventor
Hiroshi Hosono
Toshiyuki Nishio
Hiromichi Ishikawa
Yoshiyuki Nakamura
Tetsuo Matsui
Original Assignee
Senju Pharma Co
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co, Yoshitomi Pharmaceutical filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE192442T1 publication Critical patent/ATE192442T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94921848T 1993-09-14 1994-08-01 Bernsteinsäuremonoamidverbindung, verfahren zur deren herstellung und deren verwendung ATE192442T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5250925A JPH0782259A (ja) 1993-09-14 1993-09-14 スクシンアミド酸誘導体及びそれを含有する糖尿病合併症治療剤
PCT/JP1994/001266 WO1995007898A1 (en) 1993-09-14 1994-08-01 Succinamic acid compound, process for producing the same, and use thereof

Publications (1)

Publication Number Publication Date
ATE192442T1 true ATE192442T1 (de) 2000-05-15

Family

ID=17215069

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921848T ATE192442T1 (de) 1993-09-14 1994-08-01 Bernsteinsäuremonoamidverbindung, verfahren zur deren herstellung und deren verwendung

Country Status (12)

Country Link
US (1) US5688818A (de)
EP (1) EP0719767B1 (de)
JP (1) JPH0782259A (de)
KR (1) KR960704870A (de)
CN (1) CN1134699A (de)
AT (1) ATE192442T1 (de)
AU (1) AU680670B2 (de)
CA (1) CA2171756A1 (de)
DE (1) DE69424295T2 (de)
ES (1) ES2145142T3 (de)
TW (1) TW324719B (de)
WO (1) WO1995007898A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004307B1 (de) * 1998-01-30 2002-09-04 R-Tech Ueno, Ltd. Ophthalmische zubereitung
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
TWI266901B (en) 2005-12-26 2006-11-21 Au Optronics Corp Color filter and method for fabricating the same
CA3113689A1 (en) 2018-09-25 2020-04-02 Antabio Sas Indane derivatives for use in the treatment of bacterial infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822809A (en) * 1987-11-13 1989-04-18 Abbott Laboratories Benzazole lipoxygenase inhibiting compounds
JP3126541B2 (ja) * 1993-03-26 2001-01-22 千寿製薬株式会社 ベンゾチアゾール誘導体、その製法及びその用途

Also Published As

Publication number Publication date
AU7238994A (en) 1995-04-03
WO1995007898A1 (en) 1995-03-23
DE69424295D1 (de) 2000-06-08
KR960704870A (ko) 1996-10-09
US5688818A (en) 1997-11-18
EP0719767A1 (de) 1996-07-03
EP0719767A4 (de) 1997-01-08
CN1134699A (zh) 1996-10-30
AU680670B2 (en) 1997-08-07
TW324719B (en) 1998-01-11
EP0719767B1 (de) 2000-05-03
JPH0782259A (ja) 1995-03-28
ES2145142T3 (es) 2000-07-01
CA2171756A1 (en) 1995-03-23
DE69424295T2 (de) 2000-10-26

Similar Documents

Publication Publication Date Title
NO904202L (no) Terapeutisk aktive bifenylmetanderivater og fremgangsmaatefor deres fremstilling.
HUT70836A (en) 1-h-indole-3-acetamide spla2 inhibitors, process for producing them and pharmaceutical compositions comprising same compounds
HU904912D0 (en) Process for producing thiazole derivatives
ATE150749T1 (de) Substituierte heterocyclische carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel
GR3032220T3 (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation
ATE192442T1 (de) Bernsteinsäuremonoamidverbindung, verfahren zur deren herstellung und deren verwendung
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
ATE181067T1 (de) Benzothiazol-derivate, verfahren zur herstellung sowie anwendungen
AU695907B2 (en) Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
KR950700289A (ko) 퀴놀린-3-아세트산 유도체, 그의 제조법 및 용도(quinoline-3-acetic acid derivative, process for producing the same, and use thereof)
EP0644194A4 (de) Pyridothiazinessigsäure-derivate, verfahren zu deren herstellung sowie deren verwendung.
EP0802179A4 (de) Derivate substituierter amidinonaphthylester
EP0794184A4 (de) 6-methoxy-1h-benzotriazol-5-carboxamide-derivate, verfahren zur herstellung und diese enthaltende arzneimittel
DE69532963D1 (de) Verwendung von 4-acylaminopyridin derivaten zur Herstellung eines Medikaments für die Behandlung von zerebrovaskulären Erkrankungen
EP0738727A4 (de) 1,4-benzoxazin-2-essigsäureverbindung, verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties